Fintel reports that on October 30, 2025, Citigroup maintained coverage of Bio-Rad Laboratories (NYSE:BIO.B) with a Buy recommendation. Analyst Price Forecast Suggests 21.85% Upside As of April 2, 2025 ...

Q3 2025 Management View John Engel, Chairman, President & CEO, stated, "We delivered very strong results in the third quarter ...

Get Q3 2025 earnings insights for Integra LifeSciences (IART): supply chain updates, financial results, guidance revisions, and outlook.

There are only two types of investors: those who have unlawful child labor in their portfolios, and those who do not yet know that they have unlawful child labor in their portfolios. So we present ...